Igyxos’ mission is to develop innovative new pharmaceuticals and medical technologies in the field of human fertility.
Igyxos is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds such as small molecules and antibodies, and the acquisition of intellectual property rights to drugs and technologies that can then be brought to the development phase.
Igyxos also support the transfer of potential drug candidates to pre-clinical and clinical phases of drug development.